
Abinaya Vijayaraghavan
Articles
-
2 weeks ago |
ksl.com | Tom Balmforth |Sergiy Karazy |Abinaya Vijayaraghavan
CHERNIHIV REGION, Ukraine — Russia and Ukraine each released 390 prisoners on Friday and said they would free more in the coming days, in what is expected to be the biggest prisoner swap of the war so far. The agreement to exchange 1,000 prisoners each was the only concrete step towards peace to emerge last week from the first direct talks between the warring sides in more than three years, when they failed to agree on a ceasefire.
-
3 weeks ago |
businesslive.co.za | Abinaya Vijayaraghavan |Akash Sriram
Bengaluru — Tesla’s board has formed a special committee to review CEO Elon Musk’s compensation, which could result in a new stock options package, the Financial Times reported on Wednesday. The two-member committee comprises Tesla board chair Robyn Denholm and independent board member Kathleen Wilson-Thompson, the newspaper reported, citing several people familiar with the matter. Tesla did not immediately respond to a Reuters request for comment outside regular business hours.
-
1 month ago |
businesslive.co.za | Abinaya Vijayaraghavan |Chandni Shah
The US department of justice has proposed that Google sell its AdX digital advertising marketplace and DFP platform for managing and delivering ads on websites, after a federal judge found the company illegally dominated two online ad-tech markets. The proposed remedies, including divestitures, are necessary to end the Alphabet-owned tech giant’s monopolies and restore competition in the ad-exchange and publisher ad-server markets, the department of justice said in a court filing late on Monday.
-
1 month ago |
today.westlaw.com | Abinaya Vijayaraghavan |Miyoung Kim |Nivedita Bhattacharjee |Mrigank Dhaniwala
(Reuters) -The U.S. Department of Justice has proposed that Google sell its AdX digital ad marketplace and DFP platform for managing and delivering ads on websites, after a federal judge found the company illegally dominated two online ad-tech...
-
1 month ago |
today.westlaw.com | Abinaya Vijayaraghavan |Mike Scarcella |Rachel More
(Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in the United States against Amgen over the alleged entrenchment of the market position of its blockbuster medicine, Enbrel (etanercept).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →